1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Acute Upper Respiratory Tract Infections Global Clinical Trials Review, H2, 2015

Acute Upper Respiratory Tract Infections Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Acute Upper Respiratory Tract Infections Global Clinical Trials Review, H2, 2015" provides an overview of Acute Upper Respiratory Tract Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Upper Respiratory Tract Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Acute Upper Respiratory Tract Infections Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Acute Upper Respiratory Tract Infections to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Acute Upper Respiratory Tract Infections to Infectious Disease Clinical Trials 19
Clinical Trials by Phase in E7 Countries 21
Clinical Trials in E7 Countries by Trial Status 22
Clinical Trials by Phase 23
In Progress Trials by Phase 24
Clinical Trials by Trial Status 25
Clinical Trials by End Point Status 26
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Acute Upper Respiratory Tract Infections Therapeutics Clinical Trials 30
Prominent Drugs 32
Clinical Trial Profile Snapshots 33
Appendix 45
Abbreviations 45
Definitions 45
Research Methodology 46
Secondary Research 46
About GlobalData 47
Contact Us 47
Disclaimer 47
Source 48

List of Tables
Acute Upper Respiratory Tract Infections Therapeutics, Global, Clinical Trials by Region, 2015* 6
Acute Upper Respiratory Tract Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Acute Upper Respiratory Tract Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Acute Upper Respiratory Tract Infections Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Acute Upper Respiratory Tract Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Acute Upper Respiratory Tract Infections Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Acute Upper Respiratory Tract Infections Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Acute Upper Respiratory Tract Infections Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Acute Upper Respiratory Tract Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 16
Acute Upper Respiratory Tract Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 17
Acute Upper Respiratory Tract Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 18
Proportion of Acute Upper Respiratory Tract Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 20
Acute Upper Respiratory Tract Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 21
Acute Upper Respiratory Tract Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 22
Acute Upper Respiratory Tract Infections Therapeutics, Global, Clinical Trials by Phase, 2015* 23
Acute Upper Respiratory Tract Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 24
Acute Upper Respiratory Tract Infections Therapeutics, Global, Clinical Trials by Trial Status, 2015* 25
Acute Upper Respiratory Tract Infections Therapeutics Clinical Trials, Global, by End Point Status, 2015* 26
Acute Upper Respiratory Tract Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Acute Upper Respiratory Tract Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28
Acute Upper Respiratory Tract Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Acute Upper Respiratory Tract Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Acute Upper Respiratory Tract Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32

List of Figures
Acute Upper Respiratory Tract Infections Therapeutics, Global, Clinical Trials by Region (%), 2015* 6
Acute Upper Respiratory Tract Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Acute Upper Respiratory Tract Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Acute Upper Respiratory Tract Infections Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Acute Upper Respiratory Tract Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Proportion of Acute Upper Respiratory Tract Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 15
Acute Upper Respiratory Tract Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 17
Acute Upper Respiratory Tract Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 18
Proportion of Acute Upper Respiratory Tract Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 19
Acute Upper Respiratory Tract Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 21
Acute Upper Respiratory Tract Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 22
Acute Upper Respiratory Tract Infections Therapeutics, Global, Clinical Trials by Phase (%), 2015* 23
Acute Upper Respiratory Tract Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 24
Acute Upper Respiratory Tract Infections Therapeutics, Global, Clinical Trials by Trial Status, 2015* 25
Acute Upper Respiratory Tract Infections Therapeutics Clinical Trials, Global, by End Point Status, 2015* 26
Acute Upper Respiratory Tract Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Acute Upper Respiratory Tract Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 28
Acute Upper Respiratory Tract Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Acute Upper Respiratory Tract Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Acute Upper Respiratory Tract Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
GlobalData Methodology 46

Companies Mentioned
NPF Materia Medica Holding
Valeant Pharmaceuticals International, Inc.
Taisho Pharmaceutical Holdings Co., Ltd.
Rose Pharmed Biotechnology Co.
Reckitt Benckiser Group Plc
Novartis AG
Laboratoires Pierre Fabre SA
Daewon Pharm Co. Ltd.

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Bovine Respiratory Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Bovine Respiratory Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • October 2016
  • by Transparency Market Research

Global Bovine Respiratory Disease Treatment Market: Overview Bovine respiratory disease (BRD) is a multifactorial and complex disorder caused due to combination of more than one microbial pathogens, impaired ...

Chronic Obstructive Pulmonary Disease (COPD) - Market Insights, Epidemiology and Market Forecast-2023

Chronic Obstructive Pulmonary Disease (COPD) - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Chronic Obstructive Pulmonary Disease (COPD) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview ...

Allergic Rhinitis - Market Insights, Epidemiology and Market Forecast-2023

Allergic Rhinitis - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Allergic Rhinitis - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.